Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	As	-	-	-	-	[6] 46, 53, 96, 97, 215, 271 💬
2	Calcium	Calcium	-	-	-	[27]  6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬
3	Calcium gluconate	Calcium	[1] D00935 💬	-	-	[3] 214, 215, 235 💬
4	Coenzyme q10	Ubidecarenone	[1] D01065 💬	-	-	[12]  2 ,  5 ,  6 ,  8 , 10, 18, 46, 57, 113, 193, 214, 215 💬
5	Cpx	-	-	-	-	[2] 215, 299 💬
6	Device: cellvizio 100 series system with confocal miniprobes	-	-	-	-	[1] 215 💬
7	Dexmedetomidine	Dexmedetomidine	[2] D00514, D01205 💬	[3] ADRA2A, ADRA2B, ADRA2C 💬	[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway	[12]  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
8	Dobutamin	Dobutamine	[4] D00632, D03879, D03880, D03881 💬	[1] ADRB1 💬	[10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 215 💬
9	Dobutamine	Dobutamine	[4] D00632, D03879, D03880, D03881 💬	[1] ADRB1 💬	[10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	[3] 57, 58, 215 💬
10	Eplerenone	Eplerenone	[1] D01115 💬	[1] NR3C2 💬	[1] Aldosterone-regulated sodium reabsorption	[4] 75, 113, 210, 215 💬
11	Fentanyl	Fentanyl	[2] D00320, D01399 💬	[1] OPRM1 💬	[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction	[4] 46, 70, 215, 231 💬
12	Fentanyl (high dose)	Fentanyl	[2] D00320, D01399 💬	[1] OPRM1 💬	[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction	[1] 215 💬
13	Fentanyl (low dose)	Fentanyl	[2] D00320, D01399 💬	[1] OPRM1 💬	[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction	[1] 215 💬
14	Fentanyl (low dose) + dexmedetomidine	Dexmedetomidine	[4] D00320, D00514, D01205, D01399 💬	[4] ADRA2A, ADRA2B, ADRA2C, OPRM1 💬	[4] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway	[1] 215 💬
15	Fluorescite	-	-	-	-	[1] 215 💬
16	Gradient	-	-	-	-	[4] 58, 86, 149, 215 💬
17	Ketamine	Ketamine	[2] D00711, D08098 💬	[5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬	[20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway	[5] 13, 70, 113, 156, 215 💬
18	Losartan	Losartan	[2] D00357, D08146 💬	[1] AGTR1 💬	[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	[18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
19	Losartan potassium	Losartan	[3] D00357, D08146, D08403 💬	[1] AGTR1 💬	[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	[5] 36, 98, 167, 179, 215 💬
20	Other: dobutamine	Dobutamine	[4] D00632, D03879, D03880, D03881 💬	[1] ADRB1 💬	[10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 215 💬
21	Other: transthoracic echocardiography at rest, during plr, hg and cpx (including blood gas analysis in both groups). additionally fallot patients will undergo routine blood testings.	-	-	-	-	[1] 215 💬
22	Potassium	Potassium	[1] D08403 💬	-	-	[10] 36, 46, 66, 67, 98, 115, 167, 179, 215, 235 💬
23	Procedure: b-lines se	-	-	-	-	[3] 58, 86, 215 💬
24	Procedure: coronary flow reserve se	-	-	-	-	[3] 58, 86, 215 💬
25	Procedure: diastolic function se	-	-	-	-	[3] 58, 86, 215 💬
26	Procedure: left ventricular contractile reserve se	-	-	-	-	[3] 58, 86, 215 💬
27	Procedure: left ventricular outflow tract gradient se	-	-	-	-	[3] 58, 86, 215 💬
28	Procedure: mitral regurgitation se	-	-	-	-	[3] 58, 86, 215 💬
29	Procedure: pulmonary hemodynamics se	-	-	-	-	[3] 58, 86, 215 💬
30	Procedure: tof repair with trans-annular patch vs preservation of pv	-	-	-	-	[1] 215 💬
31	Pv	-	-	-	-	[3] 13, 97, 215 💬
32	Recombinant human brain natriuretic peptide (rhbnp)	-	-	-	-	[1] 215 💬
33	Sodium citrate	Sodium citrate	[2] D01781, D05855 💬	-	-	[4] 67, 214, 215, 235 💬
34	Tranexamic acid	Tranexamic acid	[1] D01136 💬	[1] PLG 💬	[4] Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection	[5] 46, 70, 215, 227, 288 💬

Back to top